No abstract available
Publication types
-
Comment
-
Randomized Controlled Trial
MeSH terms
-
Fibrinolytic Agents / therapeutic use*
-
Health Priorities
-
Humans
-
Ischemic Attack, Transient / drug therapy
-
Ischemic Attack, Transient / prevention & control*
-
Secondary Prevention